The Reagan-Udall Foundation is developing a program called Innovation in Medical Evidence Development and Surveillance (IMEDS) focused on bringing together work on surveillance research methods in order to facilitate post-market evidence generation for drugs and other medical products.
Created by Congress in 2007, the Reagan-Udall Foundation is a public-private initiative intended to advance FDA regulatory science. The IMEDS...